Largest pharmaceuticals by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Pfizer leads the 61 pharmaceuticals ranked by net assets, at $86.5B, ahead of Johnson & Johnson ($81.5B) and Sanofi ($79.2B). Figures as of 17 Nov 2026, 17:20 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
61
First
Pfizer$86.5B
Median
$878.1M
Combined market value
$5.17T
Countries
10

Market values as of .

Largest pharmaceuticals by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1PfizerPFE · Health Care$86.5B$162.7B$28.54 1.11% down 13% up United States
2Johnson & JohnsonJNJ · Health Care$81.5B$675.4B$280.57 0.70% down 41% up United States
3SanofiSNY · Health Care$79.2B$115.1B$47.93 0.96% down 4% down France
4Merck & CoMRK · Health Care$52.6B$354.9B$143.98 0.33% down 50% up United States
5Abbott LaboratoriesABT · Health Care$52.1B$184B$106.24 1.13% down 17% down United States
6AstraZenecaAZN · Health Care$48.7B$284.4B$183.39 0.34% down 3% up United Kingdom
7Takeda PharmaceuticalTAK · Health Care$46.5B$69.4B$21.71 0.56% up 53% up Japan
8NovartisNVS · Health Care$46.1B$301.9B$159.86 0.21% down 25% up Switzerland
9Regeneron PharmaceuticalsREGN · Health Care$31.3B$99.5B$961.54 0.96% up 31% up United States
10Novo NordiskNVO · Health Care$28.8B$179.3B$40.69 2.18% down 13% down Denmark
11Eli LillyLLY · Health Care$26.5B$1.26T$1,416.29 1.07% down 39% up United States
12GSKGSK · Health Care$21.7B$99.2B$49.49 1.83% down 6% up United Kingdom
13Vertex PharmaceuticalsVRTX · Health Care$18.7B$135.5B$534.47 0.62% down 23% up United States
14Bristol-Myers SquibbBMY · Health Care$18.5B$124.5B$60.93 3.19% down 34% up United States
15ViatrisVTRS · Health Care$14.7B$23.7B$20.63 0.53% down 94% up United States
16Royalty PharmaRPRX · Health Care$9.7B$39.3B$68.35 0.26% down 74% up United States
17Teva Pharmaceutical IndustriesTEVA · Health Care$7.9B$49.2B$42.14 1.01% down 71% up Israel
18United TherapeuticsUTHR · Health Care$7.1B$24.7B$579.15 1.48% down 23% up United States
19Elanco Animal HealthELAN · Health Care$6.5B$13B$26.06 1.33% down 23% up United States
20BioMarin PharmaceuticalBMRN · Health Care$6.1B$11.3B$58.39 0.69% up 7% up United States
21GrifolsGRFS · Health Care$5.8B$5.9B$8.64 1.03% down 2% up Spain
22GenmabGMAB · Health Care$5.8B$31.9B$51.80 0.45% up 70% up Denmark
23Roivant SciencesROIV · Health Care$4.5B$27.8B$38.43 0.47% down 88% up United Kingdom
24BeOne MedicinesONC · Health Care$4.4B$46.9B$410.40 0.22% down 13% up Switzerland
25Jazz PharmaceuticalsJAZZ · Health Care$4.3B$15.6B$242.34 1.07% up 33% up Ireland
26Dr. Reddy's LaboratoriesRDY · Health Care$4B$12.4B$14.89 1.29% up 5% up India
27ZoetisZTS · Health Care$3.3B$34.1B$83.85 0.64% down 29% down United States
28AlkermesALKS · Health Care$1.8B$7.7B$45.54 2.13% down 59% up Ireland
29Ligand PharmaceuticalsLGND · Health Care$1B$6B$299.42 0.76% down 46% up United States
30Legend BiotechLEGN · Health Care$1B$3.2B$16.27 1.75% up 46% down United States
31Praxis Precision MedicinesPRAX · Health Care$878.1M$8.6B$308.39 0.61% down 69% up United States
32Alnylam PharmaceuticalsALNY · Health Care$789.2M$21.1B$157.19 1.59% down 65% down United States
33Belite BioBLTE · Health Care$770.5M$6.3B$157.15 3.33% down 32% up United States
34InsmedINSM · Health Care$739M$26.3B$119.75 2.55% down 39% down United States
35Spyre TherapeuticsSYRE · Health Care$715.2M$9B$94.95 4.45% down 312% up United States
36Summit TherapeuticsSMMT · Health Care$658.9M$8.7B$10.94 7.49% down 30% down United States
37TG TherapeuticsTGTX · Health Care$648M$9.5B$62.88 0.19% up 101% up United States
38Corcept TherapeuticsCORT · Health Care$647.8M$7.8B$71.13 2.75% up 8% down United States
39Cogent BiosciencesCOGT · Health Care$636.4M$4.7B$26.98 1.68% down 18% down United States
40Protagonist TherapeuticsPTGX · Health Care$614.7M$8.2B$125.30 0.38% up 48% up United States
41Madrigal PharmaceuticalsMDGL · Health Care$602.7M$9.9B$426.93 0.70% up 24% down United States
42Kiniksa Pharmaceuticals InternationalKNSA · Health Care$567.6M$7.4B$94.56 0.35% up 128% up United Kingdom
43Edgewise TherapeuticsEWTX · Health Care$522.3M$4.6B$42.05 3.73% down 97% up United States
44ABIVAXABVX · Health Care$505.1M$7.3B$83.30 0.37% down 27% down France
45Dianthus TherapeuticsDNTH · Health Care$493.4M$4.9B$87.28 2.54% down 119% up United States
46Ionis PharmaceuticalsIONS · Health Care$489.1M$4.5B$27.05 3.43% down 62% down United States
47Oruka TherapeuticsORKA · Health Care$471.9M$6.6B$96.66 2.60% down 262% up United States
48Arrowhead PharmaceuticalsARWR · Health Care$466.1M$6.1B$43.45 1.73% down 9% up United States
49Definium TherapeuticsDFTX · Health Care$332.3M$4B$29.36 2.64% down 164% up United States
50ErascaERAS · Health Care$325.2M$5.1B$14.57 3.57% down 428% up United States
51Mirum PharmaceuticalsMIRM · Health Care$314.7M$5.9B$90.88 0.76% down 27% up United States
52Rhythm PharmaceuticalsRYTM · Health Care$139.1M$7.9B$113.72 5.80% up 7% up United States
53Travere TherapeuticsTVTX · Health Care$114.8M$4.8B$50.28 1.17% up 38% up United States
54Axsome TherapeuticsAXSM · Health Care$88.3M$7.2B$136.72 0.21% down 7% down United States
55Amneal PharmaceuticalsAMRX · Health Care-$70.8M$7.3B$21.08 0.71% down 83% up United States
56VeradermicsMANE · Health Care-$121M$5.3B$126.39 1.30% down 239% up United States
57Ascendis PharmaASND · Health Care-$180.7M$17.5B$267.14 1.69% down 25% up Denmark
58PTC TherapeuticsPTCT · Health Care-$205.3M$5B$60.05 1.51% down 20% down United States
59CytokineticsCYTK · Health Care-$659.6M$7.2B$51.87 2.44% down 20% down United States
60BridgeBio PharmaBBIO · Health Care-$2.1B$14.9B$76.63 0.94% down 18% up United States
61AbbVieABBV · Health Care-$3.3B$518.2B$293.17 0.47% down 26% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period.

Questions and answers

Which pharmaceuticals rank first by net assets?

Pfizer ($86.5B), Johnson & Johnson ($81.5B) and Sanofi ($79.2B) are the top three of the 61 pharmaceuticals ranked by net assets as of 17 Nov 2026, 17:20 UTC.

How many pharmaceuticals are in this ranking?

61 are ranked by net assets.

What are these pharmaceuticals worth together?

Their combined market value is $5.17T as of 17 Nov 2026, 17:20 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest pharmaceuticals by net assets”, data as of 17 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.